A Study to Evaluate the Safety and Efficacy of Enzalutamide in Chemotherapy-Naïve, Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Enzalutamide
Related studies linked through entity extraction aliases.
A Study to Determine Safety and Tolerability of Enzalutamide (MDV3100) in Combination With Abiraterone Acetate in Bone Metastatic Castration-Resistant Prostate Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of Enzalutamide (Formerly MDV3100) as a Neoadjuvant Therapy for Patients Undergoing Prostatectomy for Localized Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Assess the Safety of Continued Administration of MDV3100 in Subjects With Prostate Cancer Who Showed Benefit From Prior Exposure to MDV3100
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Clinical Pharmacology of GDC-0068 in Combination With Docetaxel, Fluoropyrimidine Plus Oxaliplatin, Paclitaxel, or Enzalutamide in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Test if Enzalutamide is Effective and Safe in Prostate Cancer Patients Who Have Never Had Hormone Therapy
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Determine Effect of Enzalutamide (MDV3100) on the Androgen Signaling Pathway in Correlation With the Anti-tumor Effects of Enzalutamide
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3